“…The detailed process of study selection is presented in Supplementary Figure S1. Forty-one articles reported RRs for n-6 PUFA intake only [ [24,53,58,75,80], endometrium (3 articles and 1756 cases) [31,36,85], skin (3 articles and 36,819 cases) [23,39,44], and others (ovarian, lung, liver, lymphoma, and gastric; 6 articles and 2958 cases) [25,30,47,51,83,90]. Three articles provided RRs of any type of cancer [22,38,73].…”